Month: February 2021

GHENT, Belgium, Feb. 15, 2021 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA, the “Company”), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces that its management team will participate in the following upcoming virtual investor conferences.BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference, 17-19 February 2021Company presentation by Ian Crosbie, CEO, on Thursday 18 February at 16:30 CETH.C. Wainwright Global Life Sciences Conference, 9-10 March 2021Company presentation by Ian Crosbie, CEO, available on demandBioCapital Europe, 11 March 2021Company presentation by Ian Crosbie, CEO, on Thursday 11 March at 15:55 CETTo request a one-on-one meeting with Sequana Medical management at one of these...

EURONEXT’S STATEMENT ON GOVERNANCE EVOLUTIONAmsterdam, Brussels, Dublin, Lisbon, Oslo and Paris  – 15 February 2021 – Euronext today confirms that Piero Novelli has been nominated by the Supervisory Board as an independent member of the Supervisory Board, to become the next Chairman of Euronext N.V. Mr. Novelli will step down from all executive positions before becoming Chairman. The appointment of Mr. Novelli remains subject to the approval of the relevant regulatory authorities and of Euronext shareholders.The convening notice for the General Meeting of Euronext shareholders will be sent in due course.Biography of Mr. Piero NovelliPiero Novelli has been Co-President of the Investment Bank of UBS and a member of UBS Group Executive Board since October 2018. He was appointed Co-Executive Chairman of Global Investment Banking in 2017 and...

BRISBANE, Australia, Feb. 15, 2021 (GLOBE NEWSWIRE) — Orocobre Limited (ASX: ORE, TSX: ORL) (“Orocobre” or “the Company”) advises that following an earthquake late Saturday (13 February 2021, JST) off the coast of Fukushima Prefecture, north east Japan, there are no injuries to employees at the Naraha Lithium Hydroxide Plant.An initial inspection of the plant with the construction contractor, Veolia Jenets on the morning of 14 February found some minor damage to the site office but did not find any visible defects to plant equipment. Additionally, there is no damage to site infrastructure services.A further inspection will be undertaken on 15 February to confirm the initial observations and assure the safety of the site prior to the recommencement of construction work.Authorised by:Richard S. AnthonJoint Company SecretaryFor more...

Reitir birta uppgjör ársins 2020 í lok dags mánudaginn 15. febrúar. Kynningarfundur fyrir fjárfesta og markaðsaðila verður haldinn kl. 8:30, þriðjudaginn 16. febrúar. Fundurinn verður rafrænn en þar munu Guðjón Auðunsson, forstjóri, og Einar Þorsteinsson, fjármálastjóri, kynna uppgjörið. Hægt verður að bera upp spurningar á fundinum með skriflegum hætti.Skráning er nauðsynleg fyrir þátttöku á fundinum og er hægt að skrá sig á hlekknum hér að neðan. Eftir skráningu fá þátttakendur staðfestingarpóst með nánari upplýsingum.https://us02web.zoom.us/webinar/register/5716052657619/WN_urH6ukXmRQSdaNBNeGDuHw

The Contactless Payments witnessing robust growth in the Asia-Pacific region on account of paradigm inclination of customer toward digital commerce and propelling advancements in smart chip technology. The increasing consumer base toward digital payment such as UPI, net banking, digital wallets, QR code scan, A2A payments due to burgeoning smartphone penetration the major factor for the market growth. Besides this, boost in the demand for contactless payment technology especially in financial services, rising advancement in Near Field Communication (NFC) technology, and growing awareness about these services and technologies are the factors anticipated to have a positive outlook on the market growth. Key questions answered in the study 1. What are the current and future trends of the Contactless Payments industry?2. How the industry has...

BROOKFIELD, NEWS, Feb. 13, 2021 (GLOBE NEWSWIRE) — Brookfield Infrastructure Corporation (NYSE: BIPC; TSX: BIPC) today announced that it has filed its 2020 annual report on Form 20-F (the “Annual Report”), including its audited financial statements for the year ended December 31, 2020, with the SEC on EDGAR as well as with the Canadian securities authorities on SEDAR. These documents are also available under the Financial Reports section of our website (bip.brookfield.com/bipc) and a hard copy will be provided to shareholders free of charge upon request.Brookfield Infrastructure is a leading global infrastructure company that owns and operates high-quality, long-life assets in the utilities, transport, midstream and data sectors across North and South America, Asia Pacific and Europe. We are focused on assets that generate stable...

HOUSTON, Feb. 13, 2021 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (Nasdaq:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in a public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.Roth Capital Partners is acting as the sole placement agent for the offering.Bio-Path currently intends to use the net proceeds from the offering for working capital and general corporate purposes.A shelf registration statement on Form S-3 (Registration No. 333-231537)...

Steve Muehler, the Founder & Senior Managing Member of Private Placement Markets, today announced that the last piece of the Firm’s year long products & services expansion will open in July of this year, and that is the “Private Paralegal Services Division” of the Private Placement Market. Mr. Steve Muehler will head the Firm’s Paralegal Services division when it opens. The Private Placement Markets – Paralegal Services division will be a non-attorney legal professional services firm that will provide different types of Legal Document Services to Individuals and Companies throughout the State of California for a fee without being under the supervision of a Licensed Attorney. Since the Firm will not be working directly under an attorney, there will be strict limitations as to the services and products provided, and the services...

TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) — The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) announces the granting of incentive stock options to purchase 6,496,000 common shares in the capital of the Company (the “Options”) and 2,970,000 restricted share units (the “RSUs”) to certain employees, officers and directors of the Company, subject to regulatory approval.  The Options and RSUs were granted on February 8, 2021 pursuant to the Company’s applicable incentive plans. The Options are exercisable at a price of $0.44 per share and are set to expire on February 12, 2026.  The Options and RSUs vest as follow: (a) one-third on the first anniversary of when the Options and RSUs were granted; (b) one-third on the second anniversary of when the Options and RSUs were granted; and (c) the remaining one-third on...

– COSELA is the only FDA-approved therapy that helps proactively deliver multilineage myeloprotection to patients with extensive-stage small cell lung cancer being treated with chemotherapy –– Myeloprotective efficacy of COSELA resulted in reductions in the incidence and duration of severe neutropenia, and impacted anemia and the need for rescue interventions such as growth factors and red blood cell transfusions –– G1 will host conference call Tuesday, February 16, 2021 at 8:00 a.m. ET –RESEARCH TRIANGLE PARK, N.C., Feb. 12, 2021 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved COSELA™ (trilaciclib) for injection to decrease the incidence of chemotherapy-induced myelosuppression...